• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Amorphous Solid Dispersions for Bioavailability Enhancement

    Dietary Supplement Quality Assurance Programs Critical to Natural Products Industry Success

    Manufacturing Dietary Supplements in Economic Uncertainty

    2023 Contract Manufacturing Survey

    New Possibilities for Small Batch Manufacturing
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Adragos Pharma Acquires Clinigen's Development Unit, Lamda Laboratories

    Vantage Nutrition Acquires ComboCap

    Secarna, SciNeuro Enter Research Agreement for CNS Diseases

    BioNTech Revenues Slide with Waning Demand for COVID-19 Vaccines

    Codiak BioSciences to File for Chapter 11
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    PharmaBlock Opens New R&D Facility in Pennsylvania

    Macfarlan Smith Annan Facility Marked for Closure  

    Northwest Bio, Advent BioServices Gain MHRA License for Commercial Manufacturing

    Willow, Suanfarma Complete Manufacturing Process for Cannabigerol

    Harm Reduction Therapeutics, Catalent Ink Naloxone Commercial Supply Pact
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Adare Pharma Solutions Chooses Vantage to Lead Packaging Facility Upgrade

    This is Sofgen Pharmaceuticals

    Why Sofgen Pharmaceuticals?

    Stevanato, Recipharm Partner to Develop Pre-fillable Syringes for Soft Mist Inhaler

    Chewgels™ - An Explosive Experience with Innovative Technology
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Adragos Pharma Acquires Clinigen's Development Unit, Lamda Laboratories

    Secarna, SciNeuro Enter Research Agreement for CNS Diseases

    Pharming Gets FDA Nod for Joenja

    PharmaBlock Opens New R&D Facility in Pennsylvania

    Catalent Licenses Formulation Technology to Deliver High-Concentration Biologics
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Grand River Aseptic Manufacturing Receives Zero Observations from FDA Inspection

    Sofgen's Center for Pharmaceutical Excellence (CPhE)

    Dietary Supplement Quality Assurance Programs Critical to Natural Products Industry Success

    What Does the Future of Gene Therapy Hold?

    Automated Regulatory Electronic Publishing: How is It Changing the Industry?
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    LOTTE BIOLOGICS

    TaiMed Biologics

    Syngene International Ltd.

    U.S. Pharmacopeia (USP)

    CMC Pharmaceuticals
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    LOTTE BIOLOGICS

    TaiMed Biologics

    Syngene International Ltd.

    U.S. Pharmacopeia (USP)

    CMC Pharmaceuticals
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Whither Washington?

    With a new administration, the future of the FDA may be the biggest wildcard in the outlook for CDMOs and their customers

    Gil Roth, President, Pharma & Biopharma Outsourcing Association03.07.17
    I’m celebrating my 3rd anniversary of post-Contract Pharma life on the Acela to Washington, DC, for a series of lobbying meetings and to attend a hearing by the House Energy & Commerce health subcommittee. I’m in first class, but only because I’ve ridden Amtrak so much in the past 18 months that they give me a stack of upgrade coupons.

    When I started the Pharma & Biopharma Outsourcing Association (PBOA) three years ago, I only had a vague idea of how much Congressional lobbying it would involve. I thought PBOA could be effective by working solely with FDA, but as it turns out, it’s critical to have a presence on Capitol Hill, so that we can help the House and Senate better understand the role CMO/CDMOs play in the healthcare ecosystem. All the work we did in the negotiations to reauthorize the Generic Drug User Fee Amendments (GDUFA II) would be for naught without Congress and the White House passing that legislation and signing it into law, and that makes it important that our industry has representation and a seat at the table.
    Of course, the question everyone in the industry has asked me since November is, “How will the new administration affect our sector?” My response has been, “I don’t know. And anyone who tells you they do know is full of it.”

    Certainly, there are a lot of potential actions and reactions from the administration and Congress that could trickle down to the CMO/CDMO sector. A ban on immigration and strict limits on H1B visas could curtail hiring by both in-house pharma and CMOs. A Border Adjustment Tax and/or punitive tariffs could wreak havoc on CDMO and customer business models. Repeal/replacement/repair of the Affordable Care Act could throw pharma into tumult. (I’ll note that without ACA’s individual marketplace, I likely couldn’t have made the jump to launch the PBOA.) Depending on the administration’s choice of FDA Commissioner, a lowering of regulatory standards at FDA—either in terms of drug applications or inspections—could be dangerous and lure bad actors into the market.

    The future of the FDA may be the biggest wildcard in the outlook for CDMOs and their customers. The administration’s executive order on regulations may have severe repercussions that can impact CDMOs. At present, it’s unclear whether FDA can issue significant new guidance without violating that executive order. But FDA is deeply involved in its Quality Metrics initiative, in which the agency plans to get certain data from drug marketers and their supply chain. Will the agency be able to progress from draft guidance to final version and implement Quality Metrics without having to “get rid of two existing regulations” first?

    Similarly, under the Drug Supply Chain Security Act (DSCSA), manufacturers must begin serializing all drug products at the saleable unit and case level for the U.S. market starting in Nov. 2017. However, serialization solution providers contend that FDA still needs to issue some significant guidance to finalize the requirements for serialization. If FDA’s authority is delayed, will the serialization deadline be delayed, either officially or informally? How will that affect CDMOs that have made investments in capital and time to reach compliance?

    Nearer and dearer to my heart because of all those train rides up and down the Northeast Corridor during GDUFA II negotiations, will the federal hiring freeze keep FDA from staffing up to the levels it needs in order to meet its user fee commitments? Both Senate and House members have sent letters to the White House asking for clarification on the hiring freeze’s impact on the FDA, noting that User Fees specify certain hiring levels, to be paid for by industry funds. Having spent almost a year working with FDA on issues of ANDA review and facility inspection timelines, it’s clear to me that delays cascade; a one-week delay doesn’t simply lead to extending timelines a week on the other end. FDA operates an extremely complex, interdependent system, and political disruptions can be costly for everyone.

    So, no, I don’t have any firm answers when I’m asked how the new administration will impact the CDMO sector, but I’ll be doing my best to represent our member companies and make sure our lawmakers understand the ramifications of their actions on the companies that help bring safe, cost-effective medicines to the public.


    Gil Roth
    President, Pharma & Biopharma Outsourcing Association

    Gil Roth is the President of the Pharma & Biopharma Outsourcing Association (www.pharma-bio.org). He can be reached at gil.roth@pharma-bio.org.
    Related Searches
    • Biopharma Outsourcing
    • serialization
    • it
    • fda
    Suggested For You
    5 Reasons Paper Has No Place in Contract Manufacturing 5 Reasons Paper Has No Place in Contract Manufacturing
    Mogene Mogene
    Frontida BioPharm Launches Expansion Efforts Frontida BioPharm Launches Expansion Efforts
    The FDA and Metrics The FDA and Metrics
     Vantage Consulting is First Systems Integrator to Join PBOA Vantage Consulting is First Systems Integrator to Join PBOA
    Trump Picks New FDA Commish Trump Picks New FDA Commish
    Diteba Develops IV Approach to Achieve Biowaiver Status Diteba Develops IV Approach to Achieve Biowaiver Status
    DCAT Week DCAT Week '17 Q&A: API Market Trends
    Generic Drug Trends Generic Drug Trends
    Oral Solid Dosage Outsourcing: Trends & Challenges Oral Solid Dosage Outsourcing: Trends & Challenges
    LSNE Completes Two FDA Inspections LSNE Completes Two FDA Inspections
    3D Printing Meets Pharma: Reward & Risk 3D Printing Meets Pharma: Reward & Risk
    Fujifilm Launches Bio CDMO Division Fujifilm Launches Bio CDMO Division
    The Good, the Bad, and the Donald The Good, the Bad, and the Donald
    Navigating the Shifting Landscape of Contract API Manufacturing Navigating the Shifting Landscape of Contract API Manufacturing

    Related Features

    • Information Technology
      5 Reasons Paper Has No Place in Contract Manufacturing

      5 Reasons Paper Has No Place in Contract Manufacturing

      Digital solutions create more efficient manufacturing processes and eliminate delays.
      Dave Edwards, Chief Revenue Officer, MasterControl 03.01.21

    • Mogene

      ...
      Craig Morley, CEO 11.17.20

    • Breaking News | Facilities | Industry News | Inspections
      Frontida BioPharm Launches Expansion Efforts

      Frontida BioPharm Launches Expansion Efforts

      Comes on heels of receiving FDA clearance
      05.26.17


    • Regulatory Affairs
      The FDA and Metrics

      The FDA and Metrics

      The Agency and industry continue to work together to achieve FDA’s objectives
      David Lonza, Lachman Consultant Services, Inc. 05.09.17

    • Breaking News | Industry News

      Vantage Consulting is First Systems Integrator to Join PBOA

      The Pharma & Biopharma Outsourcing Association promotes members' regulatory, legislative and business interests
      04.18.17

    Loading, Please Wait..
    Trending
    • Merck KGaA Secures Exclusive Worldwide Rights To Bavencio
    • Codiak BioSciences To File For Chapter 11
    • BioNTech Revenues Slide With Waning Demand For COVID-19 Vaccines
    • How Industry 5.0 Might Benefit Pharmaceutical Manufacturing
    • Jubilant HollisterStier Appoints Chris Preti President
    Breaking News
    • Adragos Pharma Acquires Clinigen's Development Unit, Lamda Laboratories
    • Vantage Nutrition Acquires ComboCap
    • Secarna, SciNeuro Enter Research Agreement for CNS Diseases
    • BioNTech Revenues Slide with Waning Demand for COVID-19 Vaccines
    • Codiak BioSciences to File for Chapter 11
    View Breaking News >
    CURRENT ISSUE

    March 2023

    • Amorphous Solid Dispersions for Bioavailability Enhancement
    • Dietary Supplement Quality Assurance Programs Critical to Natural Products Industry Success
    • Manufacturing Dietary Supplements in Economic Uncertainty
    • 2023 Contract Manufacturing Survey
    • New Possibilities for Small Batch Manufacturing
    • Supply Chain Risk Management
    • 3 Ways Pharma Can Outsmart Talent Challenges in 2023
    • Nutraceutical Dosage Trends: Functional Gummies Offer Alternative to Tablets and Capsules
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Melodea Launches New Plastic-Free Packaging Solution
    GOED and NASC Announce Strategic Partnership
    NPA: ‘Major Victory’ in Colorado After Amendment to Eating Disorder Bill
    Coatings World

    Latest Breaking News From Coatings World

    HOFFMANN MINERAL to Focus on Comprehensive Sustainability Strategy
    HMG and Prodrive Renew Technical Partnership
    Eastern Coatings Show Sets Schedule for Technical Papers
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs FemDx Medsystems' FalloView Device
    FDA Clears NeuroRPM Parkinson's Disease Monitoring Tech
    Vaporox Earns FDA Nod for VHT-200 Wound Care Device
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Adragos Pharma Acquires Clinigen's Development Unit, Lamda Laboratories
    Vantage Nutrition Acquires ComboCap
    Secarna, SciNeuro Enter Research Agreement for CNS Diseases
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Thread Beauty Expands Cosmetics Line at Target
    The Body Shop Expands its Refill Program in Canada
    Clinique Introduces Digital Retail Concept—Clinique Lab
    Happi

    Latest Breaking News From Happi

    Arbonne Welcomes New Executives
    Total Sales for Naples Soap Company in 2022 Increase 2% Despite Inflation, Supply Chain Issues
    IBA Supports FDA in the MoCRA Rulemaking and Implementation Process
    Ink World

    Latest Breaking News From Ink World

    hubergroup Print Solutions Presents Sustainable Portfolio at PAMEX 2023
    Weekly Recap: Packaging Inks, Toyo Ink Top This Week’s Stories
    Eastern Coatings Show Announces Schedule for Technical Papers
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    eProductivity Software acquires Tharstern Group
    Imageworx details new facility, Avery Dennison tackles recycling and more
    TLMI announces 2022 Eugene Singer Award winners
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Period Care Brand August Launches in Target Stores
    Albany International Announced CEO Succession Plan
    Ahlström Partners to Make Sustainable Butter, Margarine Packaging
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Exactech Boosts AI Expertise with Licensing Deal, Team of Scientists
    Anchor Harvey Celebrates 100th Anniversary in 2023
    Arjun Ishwar Joins Miach Orthopaedics as Sales and Marketing VP
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    onsemi Honored with Supplier of the Year 2022 Award by Hyundai Motor Group 
    Weekly Recap: Dave Rahami, Zebra, Dracula Technologies Top This Week’s Stories
    Midsummer, UCLA Collaborate on Perovskite-CIGS Tandem Solar Cells

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login